ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a second clinical trial to evaluate the effect of cannabidiol in ANANDA’s proprietary delivery ...
GREENWOOD VILLAGE, Colo. & NEW YORK--(BUSINESS WIRE)--ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been ...
ANANDA Scientific Inc., a research focused bio-pharmaceutical company revealed the first patient enrolled in the clinical trial evaluating Nantheia ATL5, an investigational drug using CBD in ANANDA's ...
Georgetown, KY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Ecofibre's Ananda Health Division, the leading provider of CBD to US independent pharmacies is pleased to announce that it has partnered with MEDISCA ...
CYNTHIANA, Ky., March 15, 2019 /PRNewswire/ -- Amplicare, a leading software automation provider for pharmacies, and Ananda Professional, the leading hemp-derived CBD manufacturer exclusively serving ...
The purpose of this study is to assess the efficacy of a hemp-based cannabidiol (CBD) product, Ananda Health Spectrum gelcaps, on the severity and duration of chemotherapy-induced peripheral ...
Letco Medical, LLC (Letco Med), the supply partner of choice for profit-conscious compounding pharmacies everywhere, and Ananda Professional, the leading hemp-derived CBD manufacturer serving ...
GREENWOOD VILLAGE, Colo. & NEW YORK--(BUSINESS WIRE)--ANANDA Scientific Inc., a biotech pharma company, announced a clinical trial to evaluate Nantheia™ ATL5, an investigational drug using cannabidiol ...
CYNTHIANA, Ky., Nov. 14, 2019 /PRNewswire/ -- Ecofibre Limited (Ecofibre, Company) (ASX: EOF, OTC - Nasdaq Intl Designation: EOFBF) today announced publication of the results of an 8-week study on ...
We at Real Tested CBD are always on the lookout for the best CBD products available for the consumers. We aim to provide a thorough review of innovative CBD products prepared according to the ...
ANANDA Scientific Inc., a research focused bio-pharmaceutical company announced approval by the US Food and Drug Administration of the IND application for a clinical trial evaluating Nantheia A1002N5S ...
LONDON - Ananda Pharma plc (AQSE:ANA, OTCQB: ANANF) has published its annual report and accounts for the year ended January 31, 2025, revealing progress in its cannabidiol (CBD) medicine development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback